Prevalence of group A β-hemolytic streptococcal throat carriage and prospective pilot surveillance of streptococcal sore throat in Ugandan school children.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 24 07 2019
revised: 13 01 2020
accepted: 13 01 2020
pubmed: 24 1 2020
medline: 25 7 2020
entrez: 24 1 2020
Statut: ppublish

Résumé

Group A β-hemolytic Streptococcus (GAS), also known as Streptococcus pyogenes, is responsible for an annual 600 million cases of acute pharyngitis globally, with 92% of those infections occurring in low-resource settings. Further knowledge of the acute streptococcal pharyngitis burden in low-resource settings is essential if serious post-streptococcal complications - rheumatic fever (RF) and its long-term sequel rheumatic heart disease (RHD) - are to be prevented. Two studies were conducted in school-aged children (5-16 years): a cross-sectional study of streptococcal pharyngeal carriage followed by a prospective cohort study of streptococcal sore throat over 4 weeks from March to April 2017. The cross-sectional study revealed an overall prevalence of GAS carriage of 15.9% (79/496, 95% confidence interval 12.8-19.5%). Among 532 children enrolled in the prospective cohort study, 358 (67%) reported 528 sore throats, with 221 (41.1%) experiencing at least one GAS-positive sore throat. The overall GAS-positive rate for sore throat was 41.8% (221/528). The GAS pharyngeal carriage rates seen in Uganda (15.9%, 95% confidence interval 12.8-19.5%) are higher than the most recent pooled results globally, at 12% (range 6-28%). Additionally, pilot data suggest a substantially higher percentage of sore throat that was GAS-positive (41.8%) compared to pooled global rates when active recruitment is employed.

Identifiants

pubmed: 31972290
pii: S1201-9712(20)30015-1
doi: 10.1016/j.ijid.2020.01.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

245-251

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Alyssa DeWyer (A)

Children's National Health System, Department of Cardiology 111 Michigan Ave NW, Washington DC, USA. Electronic address: Adewyer1@jhu.edu.

Amy Scheel (A)

Emory University School of Medicine, Atlanta, Georgia, USA.

Allison R Webel (AR)

Frances Payne Bolton School of Nursing Case Western Reserve University, Cleveland, Ohio.

Chris T Longenecker (CT)

University Hospitals Harrington Heart & Vascular Institute, Case Western Reserve University, Cleveland, Ohio, USA.

Jennipher Kamarembo (J)

Gulu Regional Referral Hospital, Gulu, Uganda.

Twalib Aliku (T)

Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.

Mark E Engel (ME)

Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.

Asha C Bowen (AC)

University of Western Australia, Perth, WA; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, WA; Perth Children's Hospital, Perth, WA.

Freddie Bwanga (F)

Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.

Ian Hovis (I)

Children's National Health System, Department of Cardiology 111 Michigan Ave NW, Washington DC, USA.

Aileen Chang (A)

Department of Dermatology, University of California, San Francisco, 505 Paranassus Avenue, San Francisco, CA, 94143, USA.

Rachel Sarnacki (R)

Children's National Health System, Department of Cardiology 111 Michigan Ave NW, Washington DC, USA.

Craig Sable (C)

Children's National Health System, Department of Cardiology 111 Michigan Ave NW, Washington DC, USA.

James B Dale (JB)

Medicine, University of Tennessee, Memphis, TN, USA.

Jonathan Carapetis (J)

University of Western Australia, Perth, WA; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, WA; Perth Children's Hospital, Perth, WA.

Joselyn Rwebembera (J)

Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.

Emmy Okello (E)

Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.

Andrea Beaton (A)

Cincinnati Children's Hospital Medical Center, Cincinnati Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH